| Dr Victoria Eva Varga-huettner, MD | |
|
624 Mcclellan St, Suite G01, Schenectady, NY 12304-1020 | |
| (518) 347-5655 | |
| (518) 347-5656 |
| Full Name | Dr Victoria Eva Varga-huettner |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 16 Years |
| Location | 624 Mcclellan St, Schenectady, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437474731 | NPI | - | NPPES |
| 03637029 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 270705 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ellis Hospital | Schenectady, NY | Hospital |
| Albany Medical Center Hospital | Albany, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany Medical College | 1759293111 | 910 |
News Archive
Reuters reports that "President Barack Obama's drive to overhaul the U.S. healthcare system may be back on track thanks to Senate efforts to cut the price tag to $1 trillion, but a bipartisan deal on the sweeping proposal still is far from certain ... Senate Finance Committee Chairman Max Baucus was upbeat last week after announcing that panel members had found ways to bring the price tag to about $1 trillion over 10 years, down from an earlier estimate of a staggering $1.6 trillion ... Instead, the core group of negotiators - three Democrats and four Republicans - issued a tepid statement on Thursday merely affirming their commitment to continue negotiations."
Since the passing of the Patient Protection and Affordable Care Act of 2010, known as Obamacare, an estimated 20 million previously uninsured U.S. citizens have gained access to health insurance.
According to the National Cancer Institute, almost 70,000 people ages 15-39 are diagnosed with cancer each year in the United States. Cancers in this adolescent and young adult (AYA) population differ quite a bit across this age span.
Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.
An infant's odd case of rare encephalitis not typically found in children led researchers to discover never before seen genetic mutations and a more accurate technique to examine the IRAK4 gene responsible for innate immunity.
› Verified 8 days ago
| Entity Name | Ellis Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487644993 PECOS PAC ID: 5890607410 Enrollment ID: O20031103000406 |
News Archive
Reuters reports that "President Barack Obama's drive to overhaul the U.S. healthcare system may be back on track thanks to Senate efforts to cut the price tag to $1 trillion, but a bipartisan deal on the sweeping proposal still is far from certain ... Senate Finance Committee Chairman Max Baucus was upbeat last week after announcing that panel members had found ways to bring the price tag to about $1 trillion over 10 years, down from an earlier estimate of a staggering $1.6 trillion ... Instead, the core group of negotiators - three Democrats and four Republicans - issued a tepid statement on Thursday merely affirming their commitment to continue negotiations."
Since the passing of the Patient Protection and Affordable Care Act of 2010, known as Obamacare, an estimated 20 million previously uninsured U.S. citizens have gained access to health insurance.
According to the National Cancer Institute, almost 70,000 people ages 15-39 are diagnosed with cancer each year in the United States. Cancers in this adolescent and young adult (AYA) population differ quite a bit across this age span.
Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.
An infant's odd case of rare encephalitis not typically found in children led researchers to discover never before seen genetic mutations and a more accurate technique to examine the IRAK4 gene responsible for innate immunity.
› Verified 8 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
Reuters reports that "President Barack Obama's drive to overhaul the U.S. healthcare system may be back on track thanks to Senate efforts to cut the price tag to $1 trillion, but a bipartisan deal on the sweeping proposal still is far from certain ... Senate Finance Committee Chairman Max Baucus was upbeat last week after announcing that panel members had found ways to bring the price tag to about $1 trillion over 10 years, down from an earlier estimate of a staggering $1.6 trillion ... Instead, the core group of negotiators - three Democrats and four Republicans - issued a tepid statement on Thursday merely affirming their commitment to continue negotiations."
Since the passing of the Patient Protection and Affordable Care Act of 2010, known as Obamacare, an estimated 20 million previously uninsured U.S. citizens have gained access to health insurance.
According to the National Cancer Institute, almost 70,000 people ages 15-39 are diagnosed with cancer each year in the United States. Cancers in this adolescent and young adult (AYA) population differ quite a bit across this age span.
Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.
An infant's odd case of rare encephalitis not typically found in children led researchers to discover never before seen genetic mutations and a more accurate technique to examine the IRAK4 gene responsible for innate immunity.
› Verified 8 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
Reuters reports that "President Barack Obama's drive to overhaul the U.S. healthcare system may be back on track thanks to Senate efforts to cut the price tag to $1 trillion, but a bipartisan deal on the sweeping proposal still is far from certain ... Senate Finance Committee Chairman Max Baucus was upbeat last week after announcing that panel members had found ways to bring the price tag to about $1 trillion over 10 years, down from an earlier estimate of a staggering $1.6 trillion ... Instead, the core group of negotiators - three Democrats and four Republicans - issued a tepid statement on Thursday merely affirming their commitment to continue negotiations."
Since the passing of the Patient Protection and Affordable Care Act of 2010, known as Obamacare, an estimated 20 million previously uninsured U.S. citizens have gained access to health insurance.
According to the National Cancer Institute, almost 70,000 people ages 15-39 are diagnosed with cancer each year in the United States. Cancers in this adolescent and young adult (AYA) population differ quite a bit across this age span.
Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.
An infant's odd case of rare encephalitis not typically found in children led researchers to discover never before seen genetic mutations and a more accurate technique to examine the IRAK4 gene responsible for innate immunity.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victoria Eva Varga-huettner, MD 624 Mcclellan St, Suite G01, Schenectady, NY 12304-1020 Ph: (518) 347-5655 | Dr Victoria Eva Varga-huettner, MD 624 Mcclellan St, Suite G01, Schenectady, NY 12304-1020 Ph: (518) 347-5655 |
News Archive
Reuters reports that "President Barack Obama's drive to overhaul the U.S. healthcare system may be back on track thanks to Senate efforts to cut the price tag to $1 trillion, but a bipartisan deal on the sweeping proposal still is far from certain ... Senate Finance Committee Chairman Max Baucus was upbeat last week after announcing that panel members had found ways to bring the price tag to about $1 trillion over 10 years, down from an earlier estimate of a staggering $1.6 trillion ... Instead, the core group of negotiators - three Democrats and four Republicans - issued a tepid statement on Thursday merely affirming their commitment to continue negotiations."
Since the passing of the Patient Protection and Affordable Care Act of 2010, known as Obamacare, an estimated 20 million previously uninsured U.S. citizens have gained access to health insurance.
According to the National Cancer Institute, almost 70,000 people ages 15-39 are diagnosed with cancer each year in the United States. Cancers in this adolescent and young adult (AYA) population differ quite a bit across this age span.
Vital Access Corporation today announced the launch of the SAVE-2 post-market clinical follow-up study. The SAVE-2 study follows the U.S. SAVE study, an IDE pivotal trial that clearly demonstrated the benefits of the VWING™ Vascular Needle Guide in restoring vascular access to hemodialysis patients with uncannulatable and deep arteriovenous fistulae.
An infant's odd case of rare encephalitis not typically found in children led researchers to discover never before seen genetic mutations and a more accurate technique to examine the IRAK4 gene responsible for innate immunity.
› Verified 8 days ago
Dr. John Angerosa Jr., M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1545 Union St, Schenectady, NY 12309 Phone: 518-346-1286 Fax: 518-346-3610 | |
Gilles Chapados, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 700 Mcclellan St, Suite 203, Schenectady, NY 12304 Phone: 518-347-2466 | |
John A Collins, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 700 Mcclellan St, Suite 203, Schenectady, NY 12304 Phone: 518-347-2466 | |
Ernest J. Lee, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 624 Mcclellan St, Suite G01, Schenectady, NY 12304 Phone: 518-347-5655 Fax: 518-347-5656 | |
Dr. Diana L Page, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 624 Mcclellan St, Suite G01, Schenectady, NY 12304 Phone: 518-347-5655 Fax: 518-347-5656 |